Renewed Interest in Clinical Research Helps Change the Conversation about Trial Participation

Over the last year consumers have monitored the development of vaccines and treatments created to address the COVID-19 pandemic, which could point to a rising interest in trial participation. Living through and monitoring the development of vaccines engaged consumers with the research process, which could be a bonus for future recruiting efforts.

This white paper focuses on recent consumer openness towards clinical research and how it represents an exciting opportunity for the biopharma industry to engage with patient communities and accelerate research. In this paper, contributing authors from IQVIA discuss ways in which our industry can drive awareness to keep the momentum going regarding participating in clinical research by highlighting the benefits it brings to the entire community.

Patient Recruitment

Predict enrollment more accurately and increase the number of patients per site using data-driven patient recruitment solutions.

Clinical Trials

Change the model of clinical research by integrating data, expertise, analytics and technology from study design through execution to power better decisions.

Clinical Research & Development Solutions

Explore our end-to-end, full service clinical development capabilities including Therapeutics expertise, Development Planning, Phase I early clinical development, Phase IIb/III and Phase IV Trials, Regulatory Submission and Post-Launch Studies.

To download files, please accept Functional Cookies. These cookies provide enhanced functionality for a better user experience.

Related solutions